Case Presentation
We present a 34-year-old HIV-infected MSM, diagnosed in April 2014 in the stage of primary HIV infection. The patient's first CD4 T cell count was 793 cells/µL and the plasma level of HIV RNA was 105 000 000 copies/µl. We followed up the patient every 4 months. He had giardiasis diagnosed in December 2015 on the occasion of the sudden onset of the next complaints: nausea, loss of appetite, watery diarrhea, bloating, foul belching and weight loss of 4 kg for 7 days. The physical examination revealed dehydration symptoms of the second grade, as well the mild abdominal tenderness. The patient's CD4 T cell count was 484 cells/µL and the plasma level of HIV RNA was 396,448 copies/µl. The laboratory examinations revealed leukocytosis again (WBc were 12 G/l) and no other abnormalities. The Diagnosis of giardiasis was confirmed by two methods: morphodiagnostic test -finding cysts in feces and immunofluorescence assay (IFA) of the feces. The patient received a 7-day course of oral Metronidazole, 750 mg given t.i.d. After the treatment the symptoms resolved and the examination of stool samples and IFA became negative.
In January 2016 the patient had similar complaints: nausea, loss of appetite, mushy diarrhea, bloating and belching. The physical examination revealed a black discoloration of the tongue -lingua villosa nigra ( Figure 1 ). The throat culture was negative. The patient did not smoke or use oral tobacco products, and he was not taking any bismuth-containing compounds or antibiotics.
The patient was treated with oral albendazole, 400 mg given q.d. for 7 days because of recurrent symptoms and repeatedly positive results of IFA and examinations of stool samples. The symptoms improved, but the stool samples were positive for Giardia after treatment. In February 2016, he received a 14-day course of oral Metronidazole, 750 mg given t.i.d., and started highly active aniretroviral therapy (HAART). The HAART regimen includes tenofovir (TDF) plus emtricitabine (FTC) plus boosted darunavir (DRV/r). After the treatment with Metronidazole and one month antiretroviral therapy diarrhea had resolved and the patient was gaining weight. His tongue returned to normal. Results of stool samples for cysts and IFA became negative in March 2016. Despite having received regimen of HAART, the patient's CD4 cell count decreased to 445 cells/µL,
Introduction
Giardia lamblia is a protozoan parasite that colonizes the upper portions of the small intestine. It is the most common protozoan isolated from human stools and can cause diarrhea and intestinal malabsorption in both HIV-positive and HIV-negative patients [1] [2] [3] [4] . The prevalence rate of diarrhea caused by Giardia lamblia in AIDS patients is higher than in those without AIDS, due to humoral immune defect in AIDS patients [5] .
The drug of choice for the treatment of giardiasis is Metronidazole (cure rates approximately 85%) [6] . Other effective drugs include: quinacrine, tinidazole, furazolidone, albendazole and paramomycin [7] .
There are several causes of treatment failures: reinfection, inadequate drug levels, immunosuppression, resistance to the drug, sequestration in the gallbladder or pancreatic ducts and unknown reasons [8] . Relapse may be found in AIDS patients. Combination of two or more drugs for a longer duration is the treatment modality to treat refractory giardiasis [7, 8] .
probably associated with a co-infection with Giardia. The plasma level of HIV RNA, however decreased significantly to 1224 copies /μl.
Discussion
Giardiasis are relatively common in homosexual populations [3, 5] . HIV-infected patients with low CD4 counts who are infected with Giardia develop severe and sometimes life-threatening disease. Although B cell dysfunction has traditionally been thought to increase both susceptibility to infection with Giardia and the rate of treatment failure, more recent evidence indicates that T cells may be important [9, 10] .
The presented patient is in the second stage of HIV infection. Most of the observed symptoms in the patient are characteristic of giardiasis. But the patient had also a symptom, not very specific for the disease -lingua villosa nigra. This is a benign condition characterised by a hair-like coating on the dorsum of the tongue. Various etiological factors have been associated with this condition -chronic tobacco, social habits such as heavy drinking of coffee, tea, use of mouthwashes, drugs like oral erythromycin, topical or systemic antibiotics and steroids [11] . Bacterial and fungal overgrowth have also been thought to play a role [12] . We excluded these etiological factors in our patient and we consider that the condition is most likely associated with giardiasis.
Initially the patient was treated with Metronidazole and the infection was temporarily eradicated. Other potentially useful drugs were used -Albendazole has known for its in vitro and in vivo efficacy in the treatment of patients with giardiasis [13, 14] . However, although at the time when the symptoms were suppressed, the microscopic stool examination remained positive. The second course of treatment with Metronidazole was more continuous continued and efficient. We consider that starting HAART and decreasing of the viral load of HIV plays also an important role in the effective treatment of giardiasis.
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